Our preferred regimen(s) |
|
Alternate regimens |
|
|
|
IV: intravenously; MSSA: methicillin-susceptible S. aureus; AUC: area under the curve; MRSA: methicillin-resistant S. aureus.
* For prosthetic valve endocarditis, we add gentamicin 3 mg/kg per day IV in 3 doses and rifampin 20 mg/kg per day orally or IV in 2 doses (maximum daily dose 600 mg) for the first 2 weeks of treatment. For other device-related infections (eg, spinal instrumentation, pacemaker, cochlear implant, baclofen pump, prosthetic joint), we add rifampin 20 mg/kg per day orally or IV in 2 doses (maximum daily dose 600 mg) for up to 2 months if rifampin is tolerated and the device remains in place.
¶ Doses up to 150 mg/kg per day in 3 or 4 doses may be used for bone and joint infections (safety data are limited).
Δ Alternative dosing is suggested for clinicians/institutions who follow AUC-guided therapeutic monitoring for vancomycin for serious MRSA infections as suggested by consensus guidelines[3]; this strategy requires input from a clinical pharmacist, who will provide recommendations for initial dosing. Refer to UpToDate content on invasive staphylococcal infections in children for details of trough-guided and AUC-guided vancomycin dosing.Do you want to add Medilib to your home screen?